Prince of Songkla University
psu.ac.thTotal trials
113
Active
8
Phase 3
16
Total enrollment
14,964
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Albendazole | — | — | — | — | — | 1 | |
| Ivermectin or albendazole | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
Top conditions
- Intraocular Pressure4
- Healthy3
- Pain3
- Postoperative Pain3
- Inadequate or Impaired Breathing Pattern or Ventilation2
- Common Bile Duct Calculi2
- High-Frequency Ventilation2
- Newborn Morbidity2
Frequently asked questions about Prince of Songkla University
- How many clinical trials does Prince of Songkla University have on ClinicalTrials.gov?
- Prince of Songkla University is listed as the lead sponsor on 113 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Prince of Songkla University's trials are in Phase 3?
- 16 of Prince of Songkla University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Prince of Songkla University focus on?
- Prince of Songkla University's most-studied conditions on ClinicalTrials.gov are Intraocular Pressure, Healthy, Pain, Postoperative Pain, Inadequate or Impaired Breathing Pattern or Ventilation.
- When are Prince of Songkla University's next clinical trial readouts?
- Prince of Songkla University has 1 upcoming primary-completion readout tracked here; the soonest is “Specific Versus Empirical Anthelminthic Treatment in Eosinophilia”, expected around 2025-12-31.